Valnoctamide as a valproate substitute with low teratogenic potential in mania: a double-blind, controlled, add-on clinical trial

Bipolar Disorders
Y BersudskyR H Belmaker

Abstract

Valproic acid's well-known teratogenicity limits its use in women of childbearing age. Valnoctamide is an analog of valproate that does not undergo biotransformation to the corresponding free acid. In mice, valnoctamide has been shown to be distinctly less teratogenic than valproate. Valnoctamide is an anticonvulsant, and we hypothesized that valnoctamide is antimanic. We performed a double-blind, five-week, add-on, controlled trial of valnoctamide in mania. Patients were treated with risperidone at doses of the physician's discretion. Valnoctamide or placebo was begun at doses of 600 mg/day and increased to 1200 mg after four days. Weekly ratings by a psychiatrist blind to the study drug were conducted using the Brief Psychiatric Rating Scale (BPRS), the Young Mania Rating Scale (YMRS), and the Clinical Global Impression (CGI). Fifteen valnoctamide patients and 17 placebo patients completed at least one post-baseline week and were included in data analysis. In all efficacy measures valnoctamide was more effective than placebo as an add-on to risperidone, using two-way analysis of variance (ANOVA) with time as the within-subject factor. Two-way ANOVA showed a significant effect of time (p < 0.001) and significant interaction be...Continue Reading

References

Mar 1, 1979·Archives of General Psychiatry·J BiedermanR H Belmaker
Nov 1, 1978·The British Journal of Psychiatry : the Journal of Mental Science·R C YoungD A Meyer
Feb 1, 1991·Clinical Pharmacokinetics·M Bialer
Jan 1, 1990·European Journal of Clinical Pharmacology·M BialerE Perucca
Feb 8, 1985·Journal of Chromatography·M Bialer, B Hoch
Oct 1, 1988·Journal of Pharmaceutical Sciences·A Haj-Yehia, M Bialer
Feb 1, 1984·Archives of General Psychiatry·E KleinR H Belmaker
Feb 18, 1994·Pharmacy World & Science : PWS·M BialerS Hadad
Oct 16, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·M Bialer
Mar 4, 2000·The American Journal of Psychiatry·A MishoryR H Belmaker
Dec 12, 2000·European Psychiatry : the Journal of the Association of European Psychiatrists·P LemoineT Faivre
Feb 4, 2003·The British Journal of Psychiatry : the Journal of Mental Science·Laksami N YathamArun Ravindran
Jul 30, 2004·The New England Journal of Medicine·R H Belmaker
Oct 7, 2004·Journal of Affective Disorders·Christer EngströmPer-Olof Nylander
Dec 3, 2004·The New England Journal of Medicine·Raz GrossMyrna M Weissman
Dec 4, 2004·Biological Psychiatry·Galit ShaltielGalila Agam
Mar 23, 2005·Neurology·Marianne CunningtonUNKNOWN International Lamotrigine Pregnancy Registry Scientific Advisory Committee
May 6, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Rulun ZhouHusseini K Manji
Aug 2, 2005·The American Journal of Psychiatry·S Nassir Ghaemi, Frederick K Goodwin
Aug 2, 2005·The American Journal of Psychiatry·Robert M A HirschfeldJohn S McIntyre
Aug 2, 2005·The American Journal of Psychiatry·Jeffrey C Fetter, Kathleen D Askland
Feb 2, 2006·The American Journal of Psychiatry·Michael H AllenCharles L Bowden
Jan 3, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Meir Bialer, Boris Yagen
May 15, 2007·Neuroscience and Biobehavioral Reviews·Michael K RoweDe-Maw Chuang
Apr 12, 2008·Bipolar Disorders·D Jeffrey NewportRoss J Baldessarini
Mar 31, 2009·Advances in Therapy·Ha T T NguyenRoger S McIntyre
Apr 17, 2009·The New England Journal of Medicine·Kimford J MeadorUNKNOWN NEAD Study Group
Sep 17, 2009·Biochemical Society Transactions·Richard P Bazinet
May 11, 2010·Neuropsychobiology·Yamima OsherR H Belmaker

❮ Previous
Next ❯

Citations

May 25, 2012·European Archives of Psychiatry and Clinical Neuroscience·Konstantinos N FountoulakisEduard Vieta
Aug 31, 2011·Current Psychiatry Reports·Marsal Sanches, Jair C Soares
Sep 29, 2012·BMC Medicine·Rh BelmakerGalila Agam
Aug 20, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ayman El-FahamHoong-Kun Fun
Aug 21, 2015·Bipolar Disorders·Bogdan J WlodarczykRichard H Finnell
Sep 23, 2016·Virology·Sara OrnaghiAnthony N van den Pol
Sep 8, 2017·International Journal of Molecular Sciences·Alexei P KudinWolfram S Kunz
Jan 1, 2010·Nature Reviews. Drug Discovery·Meir Bialer, H Steve White
May 18, 2019·Expert Opinion on Pharmacotherapy·Ganna BalaguraPasquale Striano
Dec 6, 2019·The International Journal of Neuropsychopharmacology·Konstantinos N FountoulakisHans Jurgen Moeller
Nov 25, 2016·The Cochrane Database of Systematic Reviews·Yijun WangStefan Leucht
Jun 7, 2013·Expert Review of Neurotherapeutics·Marco Mula
Dec 2, 2020·Viruses·Sabina AndreuJosé Antonio López-Guerrero
Feb 23, 2021·Expert Opinion on Pharmacotherapy·Ahmad Sleem, Rif S El-Mallakh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.